Ethyl (E)-4-[2-(5,5-dimethyl-8-(thiazol-2-yl)-5,6-dihydronaphthalen-2-yl)ethenyl]-benzoate | 201141-29-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: Ethyl (E)-4-[2-(5,5-dimethyl-8-(thiazol-2-yl)-5,6-dihydronaphthalen-2-yl)ethenyl]-benzoate
• 英文别名: ethyl 4-[(E)-2-[5,5-dimethyl-8-(1,3-thiazol-2-yl)-6H-naphthalen-2-yl]ethenyl]benzoate
• CAS: 201141-29-9
• 化学式: C₂₆H₂₅NO₂S
• 分子量: 415.556
• InChiKey: DVXHLJSRNMARBL-AATRIKPKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.6
• 重原子数：
  30
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  67.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  Ethyl (E)-4-[2-(5,5-dimethyl-8-(thiazol-2-yl)-5,6-dihydronaphthalen-2-yl)ethenyl]-benzoate 生成 (E)-4-[2-(5,5-dimethyl-8-(thiazol-2-yl)-5,6-dihydronaphthalen-2-yl)ethenyl]-benzoic acid
  参考文献：
  名称：

  O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

  摘要：

  式中符号的含义如申请中所述，具有类视黄醇或类视黄醇拮抗剂样的生物活性。

  公开号：

  US06344561B2
• 作为产物：
  描述：

  噻唑 、 ethyl (E)-4-[2-(5,6-dihydro-5,5-dimethyl-8-(trifluoromethylsulfonyl)oxy-naphthalen-2-yl)ethenyl]-benzoate 在 四(三苯基膦)钯 正丁基锂 、 zinc(II) chloride 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 3.75h， 生成 Ethyl (E)-4-[2-(5,5-dimethyl-8-(thiazol-2-yl)-5,6-dihydronaphthalen-2-yl)ethenyl]-benzoate
  参考文献：
  名称：

  O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

  摘要：

  式中符号的含义如申请中所述，具有类视黄醇或类视黄醇拮抗剂样的生物活性。

  公开号：

  US06344561B2

文献信息

• Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
  申请人：——

  公开号：US20020173631A1

  公开（公告）日：2002-11-21

  Compounds of the formula 1 where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity.

  式子1中的符号所描述的化合物具有类视黄醇或类视黄醇拮抗剂类似的生物活性。
• O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
  申请人：——

  公开号：US20030078440A1

  公开（公告）日：2003-04-24

  Compounds of the formula 1 where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity.

  符号具有申请中所描述的含义的公式1的化合物具有类视黄醇或类视黄醇拮抗剂样的生物活性。
• Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
  申请人：——

  公开号：US20020156054A1

  公开（公告）日：2002-10-24

  Aryl-substituted and aryl and (3-oxo-1-propenly)-substituted benzopyran, benzothiopyran, 1,2-dihydroquinoline, and 5,6-dihydronaphthalene derivatives have retinoid negative hormone and/or antagonist-like biological activities. The invented RAR antagonists can be administered to mammals, including humans, for the purpose of preventing or diminishing action of RAR agonists on the bound receptor sites. Specifically, the RAR agonists are administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors. The retinoid negative hormones can be used to potentiate the activities of other retinoids and nuclear receptor agonists. For example, the retinoid negative hormone called AGN 193109 effectively increased the effectiveness of other retinoids and steroid hormones in in vitro transactivation assays. Additionally, transactivation assays can be used to identify compounds having negative hormone activity. These assays are based on the ability of negative hormones to down-regulate the activity of chimeric retinoid receptors engineered to possess a constitutive transcription activator domain.

  芳基取代和芳基和(3-氧代-1-丙烯基)-取代的苯并吡喃、苯并硫吡喃、1,2-二氢喹啉和5,6-二氢萘衍生物具有视黄醇负性激素和/或拮抗剂样生物活性。发明的RAR拮抗剂可用于哺乳动物，包括人类，以预防或减轻RAR激动剂对受体位点的作用。具体而言，可以与视黄醇药物共同使用RAR激动剂，以预防或改善视黄醇或维生素A或维生素A前体引起的毒性或副作用。视黄醇负性激素可用于增强其他视黄醇和核受体激动剂的活性。例如，名为AGN 193109的视黄醇负性激素在体外转录激活实验中有效增强了其他视黄醇和类固醇激素的效果。此外，可以使用转录激活实验来鉴定具有负性激素活性的化合物。这些实验基于负性激素下调工程化嵌合视黄醇受体的构成转录激活子域的能力。
• O- or S- substituted tetrahydronaphthalene derivatives having retinoid
  申请人：ALLERGAN

  公开号：US05741896A1

  公开（公告）日：1998-04-21

  Compounds of the formula ##STR1## where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity.

  式子为##STR1##的化合物，其中符号的含义在申请中有描述，具有类视黄醇或类视黄醇拮抗剂的生物活性。
• Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or
  申请人：Allergan

  公开号：US05747542A1

  公开（公告）日：1998-05-05

  Compounds of the formula ##STR1## where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity.

  式子##STR1##所表示的化合物，其中符号的含义在申请书中有描述，具有类视黄醇或类视黄醇拮抗剂样的生物活性。